Vendor, Palo Alto, CA
Palogen, Inc.
UEI RGQTLPFQ7TG6, CAGE 95M76
1 award and -$6,500,000 obligated between February 28, 2024 and March 13, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | -$6,500,000 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N92021C00025Definitive Contract, February 28, 2024, Not Competed, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Radx Tech 2 Project Number 13139 Palogen Innovative Ultra-Fast Chip Technology for Covid-19 Rna DetectionNAICS 325413, PSC Q301 | -$6,500,000 |
- Product and service codes
- Q301 Reference Laboratory Testing
- Transactions
- 2 across 1 awards